Subha Madhavan

Precision Medicine & Digital Health Leader, Data scientist, Great boss award, Force multiplier, Service to America award, Startup & NonProfit Board Governance

[Subha Madhavan @subhamadhavan]

@NLMdirector Thank you for your leadership and vision that has touched so many. Excited for your next phase. Cheers!

[Subha Madhavan @subhamadhavan]

#ASCO22 excited to reconnect with these two amazing breast cancer leaders @DrLauraEsserman @claudine_isaacs

[Subha Madhavan @subhamadhavan]

Super excited about this panel with @TClozel @NCIJBSloan Jim Chen and @ihuerga at #BioIT22 next week. Join us in person or virtually to discuss how #AI is transforming #oncology R&D and care delivery. https://t.co/7zbZOpbKGJ

[Cindy Crowninshield @C_Crowninshield]

Leading experts discuss applications, pitfalls, and future directions for applications of AI in oncology in the AI for Oncology, Precision Medicine, and Health track @ Bio-IT this May! https://t.co/Bais8Cxdk1
#BioIT22
@bioitworld
#medicine #research #health #ai
@subhamadhavan

[Subha Madhavan @subhamadhavan]

Thrilled to see this work on standardized evidence for evaluating NTRK fusions in patients published with amazing co-authors #precisiononcology #DataScience #evidencebasedmedicine

[Alanna Church, MD @AlannaChurch_MD]

Important features when evaluating a potentially oncogenic fusion like LMNA-NTRK1: ✅stranding and directionality ✅ kinase domain preserved ✅ in-frame https://t.co/nfvyEjj34T

[Daniel Kraft, MD @daniel_kraft]

#DigitalHealth COVID-19 Impact Assessment: Lessons Learned and Compelling Needs

In @theNAMedicine by @peteratmsr, @dramyabernethy , @DShaywitz, Adi Gundlapalli, Jim Weinstein, P. Murali Doraiswamy, @kevin_schulman, & @subhamadhavan

https://t.co/eAgdZxypQs

[Subha Madhavan @subhamadhavan]

@embimd @IBJnews @Regenstrief You are indeed a super hero Peter! very well deserved.

[Cancer Genomics Consortium (CGC) @CG_Consortium]

Invited Speaker @subhamadhavan presented incredibly innovative work at #CGCAnnual2021 using #AI, #NLP, and expert crowdsourcing approaches to enable precision medicine, match patients to trials, automatically identify adverse events, and standardize curation of somatic variants.

[Subha Madhavan @subhamadhavan]

Presentation by @DespinaKontos from @PennMedicine at #ASCO21 where her team applies #machinelearning to radiomics, clinical and molecular features to develop treatment plans for cancer patients. New approaches with #datascience #digitalhealth for #cancercare

[Subha Madhavan @subhamadhavan]

Terrific graphic that highlights differences between lung and breast clinical communities in terms of uptake of precision medicines. #ASCO21’s theme of access to (right) care is clearly important.

[Stephen V Liu, MD @StephenVLiu]

Thought provoking graphic. I would say that despite initial (healthy) debate, most of us in the lung cancer space are recommending adjuvant osimertinib where available. #LCSM #ASCO21

[Subha Madhavan @subhamadhavan]

@NCIDirector shares his opening remarks @ASCO #ASCO2021. Since 1990, there has been a 30% drop in cancer mortality due to behavior modifications like tobacco cessation and new/exciting drugs such as immunotherapies and targeted therapies.

[Gerson Rolim @GersonRolim]

The future of Clinical Trials: how #AI, #BigTech, & #Covid19 could make drug development cheaper, faster & more effective #DX #ML

V/@CBinsights @GersonRolim @intellimetri

https://t.co/ZiZJ6sbHdt

#100DaysOfCode #WomenWhoCode #100DaysOfMLCode #HealthTech #Coding #Chatbot #Python

[Subha Madhavan @subhamadhavan]

@lan24hd Sorry for your loss. Deepest condolences to all members of the family.

[Subha Madhavan @subhamadhavan]

@StephenVLiu @glenechopark This was my son’s favorite weekend spot many years ago. So excited to see that it continues to attract children.

[Georgetown Health Informatics & Data Science @Georgetown_HIDS]

Congratulations to @Georgetown_HIDS alumni Fuyuan Wang! He recently joined @FredNatLab subcontractor Essential Software as Software Engineer.
Apply to our one year industry driven #HealthInformatics & #DataScience Masters Program. Deadline July 1st: https://t.co/iMyirkC1dN

[Mark Hoffman @markhoffmankc]

Great #Nexusinformatics talk by @subhamadhavan describing virtual molecular tumor board.

[Dennis Ridenour @DennisRidenour]

Loving the first keynote from @subhamadhavan of @ICBI_Georgetown on Virtual Molecular Tumor Boards at the #NexusInformatics Conference with @BioNexusKC @ChildrensMercy @clevelandunivkc @KansasCityU

[Subha Madhavan @subhamadhavan]

@DShaywitz @timmermanreport Terrific post and Happy Sunday! Love the characterization of bilingual experts in data science and medical science. Would be interesting to see what opportunities are being seized by these experts in subsequent TR column.

[Subha Madhavan @subhamadhavan]

@english_august @POTUS @BarackObama @JoeBiden >40 years of public service!

[Subha Madhavan @subhamadhavan]

@DShaywitz @allo_vir @RedSox @ScottGottliebMD wow! great news and congrats to Diana! Happy to have you on eastern time zone!